ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.275
-0.01%
Bitcoin
67,820.17
-0.49%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biogen Inc (BIIB)

  7. Biogen Inc (BIIB) News

BIIB

Biogen (BIIB)

Biogen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIIB
DateTimeSourceHeadlineSymbolCompany
07/17/20245:45AMPR Newswire (US)The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIIBNASDAQ:BIIBBiogen Inc
07/16/20244:00AMPR Newswire (US)Biogen Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BIIBNASDAQ:BIIBBiogen Inc
07/12/20245:45AMPR Newswire (US)Biogen Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIIBNASDAQ:BIIBBiogen Inc
07/03/20245:45AMPR Newswire (US)July 22, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIIBNASDAQ:BIIBBiogen Inc
07/02/20249:16AMGlobeNewswire Inc.Biogen Completes Acquisition of Human Immunology BiosciencesNASDAQ:BIIBBiogen Inc
06/28/20246:50AMIH Market NewsNike Stock Drops 14% in Pre-Market; Nokia Acquires Infinera for $2.3 Billion, and More NewsNASDAQ:BIIBBiogen Inc
06/28/20245:45AMPR Newswire (US)BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:BIIBBiogen Inc
06/27/20247:39PMGlobeNewswire Inc.“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in ChinaNASDAQ:BIIBBiogen Inc
06/25/20245:45AMPR Newswire (US)Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:BIIBBiogen Inc
06/20/20245:45AMPR Newswire (US)Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIBNASDAQ:BIIBBiogen Inc
06/17/20245:45AMPR Newswire (US)Shareholders of Biogen Inc. Should Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIBNASDAQ:BIIBBiogen Inc
06/10/20245:45AMPR Newswire (US)Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:BIIBBiogen Inc
06/09/20247:37PMGlobeNewswire Inc.FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s DiseaseNASDAQ:BIIBBiogen Inc
06/09/20247:30PMPR Newswire (US)FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's DiseaseNASDAQ:BIIBBiogen Inc
06/05/20245:45AMPR Newswire (US)Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIBNASDAQ:BIIBBiogen Inc
06/04/20249:10AMIH Market NewsEconomic Worries May Lead To Weakness On Wall StreetNASDAQ:BIIBBiogen Inc
06/03/20247:30AMGlobeNewswire Inc.Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air TravelNASDAQ:BIIBBiogen Inc
05/30/20244:51PMGlobeNewswire Inc.Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSNASDAQ:BIIBBiogen Inc
05/23/20247:40AMIH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNASDAQ:BIIBBiogen Inc
05/22/20247:30AMGlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesNASDAQ:BIIBBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:BIIBBiogen Inc
05/16/20247:30AMPR Newswire (US)Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:BIIBBiogen Inc
05/14/20247:33PMGlobeNewswire Inc.Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track StatusNASDAQ:BIIBBiogen Inc
05/14/20247:30PMPR Newswire (US)Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusNASDAQ:BIIBBiogen Inc
05/02/20247:30AMGlobeNewswire Inc.Biogen Reports Progress on Corporate Responsibility PrioritiesNASDAQ:BIIBBiogen Inc
03/31/20247:30PMPR Newswire (US)Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDANASDAQ:BIIBBiogen Inc
03/06/20247:30AMGlobeNewswire Inc.New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene TherapyNASDAQ:BIIBBiogen Inc
03/04/20244:15PMGlobeNewswire Inc.Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual MeetingNASDAQ:BIIBBiogen Inc
02/26/20247:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIIBBiogen Inc
02/23/20247:00AMGlobeNewswire Inc.Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMPNASDAQ:BIIBBiogen Inc
 Showing the most relevant articles for your search:NASDAQ:BIIB

Your Recent History

USOTC
BIEL
Bioelectronics (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved